Asia Pacific Adhesion Barrier Market

Asia Pacific Adhesion Barrier Market Size & Growth (2023 to 2028):

As per the research report, the size of the Asia Pacific Adhesion Barrier Market was valued at USD 185.17 million in 2023 and estimated to be growing at a CAGR of 10.1%, to reach USD 299.58 million by 2028.

DRIVERS

The region's demand for better healthcare facilities, medical devices, and technologies is being driven by a rapidly growing geriatric population, an epidemiological shift from infectious to chronic diseases, increased life expectancy, the expansion of private-sector hospitals in these areas, and an increased demand for surgical interventions. Because there are no alternative medications available for surgical adhesion prevention, using adhesion barriers is an effective way to reduce or avoid the occurrence, severity, extent, and consequences of post-surgical adhesions. Adhesive barriers are the only option for post-surgical adhesions, which is projected to increase demand for them throughout the forecast period. The use of adhesion barriers is becoming more common as the number of surgical operations grows. Growing awareness about the usage of adhesion barriers after surgery in the Asia Pacific region is expected to fuel demand for adhesion barriers and, as a result, contribute to market development during the forecast period.

RESTRAINTS

The APAC Adhesion Barrier Market is expected to be hampered by the restricted uses of a few product types of adhesion barriers and the high cost of surgeries.

OPPORTUNITIES

The growing need for and availability of adhesion barriers for use in abdominal, gynecologic, orthopedic, cardiovascular, reconstructive, and urological procedures is likely to provide huge growth opportunities for APAC Adhesion barrier manufacturers. The expansion of this market is being fueled by an increase in the number of surgeries and sports-related injuries, as well as an increase in the elderly population and increased awareness of adhesion formation and related diseases.

The growing disease burden and amount of surgical procedures performed in this region are likely to provide growth opportunities for adhesion barrier market players. Because of the serious consequences of post-surgery adhesions in patients, the market for treatments like adhesion barriers is growing. In addition, as the number of surgeries performed in the APAC region rises, the relevance of these products will expand in the future years.

CHALLENGES

With the increased risk of post-operative adhesion, however, the industry continues to face challenges in terms of accessibility, health education, and awareness of the importance of treatment. New adhesion barriers need significant investment, and new products often take more than 7–8 years to gain marketing approval. The cost and time it takes for a product to undergo clinical trials and then pass those tests is extremely expensive, with just a small possibility of the product receiving approval.

This research report on the Asia Pacific Adhesion Barrier Market has been segmented and sub-segmented into the following categories:

By Product:

• Synthetic
• Natural

By Product Form:

• Film
• Gel
• Liquid                                                                                                           

By Surgical Application:

• Gynaecological
• Cardiovascular
• Neurological
• Orthopaedic
• General/Abdominal
• Urological
• Reconstructive

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

REGIONAL ANALYSIS

The adhesion barrier market in APAC is expected to develop at the quickest rate during the forecast period, owing to rising medical tourism and an ageing population that is more vulnerable to injuries and fractures, all of which lead to a rise in the number of surgeries. Furthermore, major firms are investing in the region's undeveloped market as part of their business strategy, resulting in the region's fastest development. Due to the expanding elderly population and increasing prevalence of cardiac and neurosurgery, which necessitate surgical treatments, Asia-Pacific is expected to surpass all other areas by recording the greatest CAGR from 2022 to 2027.

 Furthermore, the market in the area is expected to be driven by increased private sector investment in healthcare and quickly developing medical tourism. Due to its enormous population and developing healthcare industry, Asia Pacific is the most lucrative healthcare market. With a large and expanding population, the total disease prevalence in nations like China and India is increasing at an alarming rate.

The Top companies leading in the APAC Adhesion Barrier Market profiled in the report are Baxter International Inc., Medtronic Plc., C. R. Bard, Inc., Johnson & Johnson, Sanofi Group, Atrium Medical Corporation, Integra Lifesciences Corporation, Anika Therapeutics Inc., FzioMed, Inc., and MAST Biosurgery AG.